In GBM cells, QKI can associate with and stabilize miR-20a, thus, increasing miR-20a down-regulatory effects on TGF-β receptor type II (TGF-βR2), whose activity is oncogenic in gliomagenesis [17]. The gene discussed is QKI; the disease is glioblastoma.